Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study

Atezobeva is effective in both Child Pugh A and B patients. The possibility to resume treatment after an episode of decompensation underscores the importance of integrated hepato-oncological management.

Authors

Institutions

Publication Details

Journal
Clinical Gastroenterology and Hepatology
Published
2025-02-26
DOI
https://doi.org/10.1016/j.cgh.2024.12.028
Citations
9
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
11.90
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study

Leonardo Stella, Francesco Tovoli, Giuseppe Cabibbo, Elisa Pellegrini et al.
9 citations
Clinical Gastroenterology and Hepatology
Hepatocellular Carcinoma Treatment and Prognosis
11.90
article

Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study

Leonardo Stella, Francesco Tovoli, Giuseppe Cabibbo, Elisa Pellegrini, Antonio Gasbarrini, Fabio Piscaglia, Clémence Hollande, Sabrina Sidali, Francesco Santopaolo, Claudia Campani, Francesca Romana Ponziani, Maria Pallozzi, Bernardo Stefanini, Maurizio Pompili, Fabio Marra, Mohamed Bouattour, Lucia Cerrito
article en
9 citations

Abstract

Atezobeva is effective in both Child Pugh A and B patients. The possibility to resume treatment after an episode of decompensation underscores the importance of integrated hepato-oncological management.

Clinical Gastroenterology and HepatologyVol. 23(13)
Università Cattolica del Sacro Cuore (IT), Inserm (FR), Hôpital Beaujon (FR), Agostino Gemelli University Polyclinic (IT), Hôpital Cochin (FR), Assistance Publique – Hôpitaux de Paris (FR), Centro Clinico Nemo (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Azienda USL di Bologna (IT), Centre de Recherche sur l'Inflammation (FR), University of Florence (IT), University of Palermo (IT), University of Bologna (IT)
Zero hunger
Openalex Percentile: Top 1%
Hepatocellular Carcinoma Treatment and Prognosis
11.90
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.